Medicare Complexity and Insurance Delays Linked to Fatal Suicide of COPD Patient in Texas

Key points

• Kenney Blewett, diagnosed with COPD over a decade ago, experienced severe flare-ups in 2026 that left him unable to perform basic tasks and resulted in a 45-pound weight loss.
• On June 2, 2026, his pulmonologist prescribed a new liquid inhaler medication, but Walgreens reported an 'insurance issue' preventing immediate filling.
• Cindy Blewett faced confusion regarding which insurance plan covered the drug, as it fell under Medicare Part B's durable medical equipment benefit rather than his private Part D plan.
• Walgreens claimed a missing diagnostic code caused the delay, while the pulmonologist’s office denied receiving a request for that code from the pharmacy.
• Blewett died by suicide on June 7, 2026, leaving a note stating his health was too poor to continue living; a second medication ordered directly from the manufacturer arrived weeks after his death.
• Cindy Blewett has sought answers from Medicare, Centene (Wellcare), and Walgreens but remains unclear on who was responsible for the delay.

Background

This incident occurs amid growing public frustration with insurance delays, with nearly 70% of adults calling them a major problem. Although the Trump administration secured a voluntary industry pledge in June 2025 to reduce barriers, KFF Health News reported in July that some signatories failed to implement promised changes. Additionally, Medicare launched an AI pilot for prior authorization in six states, including Texas, in January 2026, which critics argue may increase red tape for beneficiaries. The archive notes unrelated insurance disputes in entertainment, but this case focuses on healthcare access.

Why it matters

The Blewett case illustrates the life-threatening consequences of bureaucratic failures in the U.S. healthcare system. It exposes gaps in coordination between pharmacies, providers, and insurers, particularly regarding Medicare Part B and Part D distinctions. As AI-driven prior authorization expands, the risk of erroneous delays and denials may increase, potentially exacerbating mental health crises for vulnerable patients with chronic conditions.

What to watch

Cindy Blewett continues to seek accountability from Medicare, Centene, and Walgreens, potentially involving legal action. The CMS AI pilot for prior authorization is expected to expand to more services and states, raising concerns about increased administrative hurdles for Medicare beneficiaries. Advocates like Matt Toresco of Archō are pushing for greater patient assistance in navigating insurance complexities.